Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study

CONCLUSION: As these beta glucans are well known food supplements with a track record for safety, larger multi-centric clinical studies are recommended to validate their use as an adjunct in the management of COVID-19 and the ensuing long COVID-19 syndrome.PMID:34840031 | PMC:PMC8463314 | DOI:10.1016/j.biopha.2021.112243

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - November 29, 2021 Category: Drugs & Pharmacology Authors: Kadalraja Raghavan Vidyasagar Devaprasad Dedeepiya Vaddi Suryaprakash Kosagi-Sharaf Rao Nobunao Ikewaki Tohru Sonoda Gary A Levy Masaru Iwasaki Rajappa Senthilkumar Senthilkumar Preethy Samuel Jk Abraham Source Type: research